GlaxoSmithKline LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 1011 North Arendell Ave, Zebulon, North Carolina (NC) 27597, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 1033964 · DUNS 149372109
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2026-02-20
- VAIDrug Quality Assurance2024-04-19
- NAIDrug Quality Assurance2018-01-26
- VAIDrug Quality Assurance2016-04-21
- NAIDrug Quality Assurance2015-08-21
- NAIDrug Quality Assurance2013-05-03
- NAIDrug Quality Assurance2009-11-20
- NAIDrug Quality Assurance2009-08-24
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- Sumatriptan Succinate and Naproxen SodiumCurrax Pharmaceuticals LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.